• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗中前列腺癌筛查的试点研究。

Pilot study of screening for prostate cancer in general practice.

作者信息

Chadwick D J, Kemple T, Astley J P, MacIver A G, Gillatt D A, Abrams P, Gingell J C

机构信息

Horfield Health Centre, Bristol, UK.

出版信息

Lancet. 1991 Sep 7;338(8767):613-6. doi: 10.1016/0140-6736(91)90615-v.

DOI:10.1016/0140-6736(91)90615-v
PMID:1715503
Abstract

The success of a screening programme for cancer depends on the sensitivity of the tests used and on the proportion of the target population that comes forward for screening. To assess the value of digital rectal screening and prostate-specific antigen (PSA) measurement as screening measures, the 814 men in a city general practice aged between 55 and 70 were recruited in one of five different ways. Men with a palpably suspicious prostate or a serum PSA greater than 4 ng/ml were referred for transrectal ultrasonography and, if indicated, biopsy. 472 men (58%) were screened; of these 68 underwent transrectal ultrasonography and 29 biopsy. In 7 the biopsy specimen showed carcinoma. Serum PSA was better than digital examination as a screening test--all men with prostate cancer had raised concentrations of serum PSA, whereas only 1 had a palpably abnormal prostate. All 7 had localised disease, and 5 underwent radical prostatectomy. The best methods of patient recruitment were to send an appointment for screening and to "tag" the patient's notes.

摘要

癌症筛查项目的成功取决于所使用检测方法的敏感性以及主动前来接受筛查的目标人群比例。为评估直肠指检和前列腺特异性抗原(PSA)检测作为筛查手段的价值,以五种不同方式之一招募了该市一家普通诊所中年龄在55至70岁之间的814名男性。前列腺可触及可疑或血清PSA大于4 ng/ml的男性被转诊进行经直肠超声检查,如有必要则进行活检。472名男性(58%)接受了筛查;其中68人进行了经直肠超声检查,29人进行了活检。7例活检标本显示为癌。血清PSA作为筛查检测方法优于直肠指检——所有前列腺癌患者的血清PSA浓度均升高,而只有1例前列腺可触及异常。所有7例均为局限性疾病,5例接受了根治性前列腺切除术。最佳的患者招募方法是发送筛查预约通知并在患者病历上“标记”。

相似文献

1
Pilot study of screening for prostate cancer in general practice.基层医疗中前列腺癌筛查的试点研究。
Lancet. 1991 Sep 7;338(8767):613-6. doi: 10.1016/0140-6736(91)90615-v.
2
PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors.对无症状年轻男性进行基于前列腺特异性抗原(PSA)的前列腺癌筛查:献血者的初步研究
Prostate. 1997 Jan 1;30(1):20-5. doi: 10.1002/(sici)1097-0045(19970101)30:1<20::aid-pros3>3.0.co;2-p.
3
Prostate cancer detection at low prostate specific antigen.低前列腺特异性抗原水平下的前列腺癌检测
J Urol. 2000 Mar;163(3):806-12.
4
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.直肠指检作为前列腺癌筛查试验的评估。欧洲前列腺癌筛查随机研究鹿特丹分部。
J Natl Cancer Inst. 1998 Dec 2;90(23):1817-23. doi: 10.1093/jnci/90.23.1817.
5
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.数字直肠检查与血清前列腺特异性抗原在前列腺癌早期检测中的比较:6630 例男性多中心临床试验结果。
J Urol. 2017 Feb;197(2S):S200-S207. doi: 10.1016/j.juro.2016.10.073. Epub 2016 Dec 22.
6
Screening for prostatic carcinoma with prostate specific antigen.用前列腺特异性抗原筛查前列腺癌。
J Urol. 1992 Mar;147(3 Pt 2):841-5. doi: 10.1016/s0022-5347(17)37401-3.
7
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.筛查试验在前列腺癌检测中的价值。第二部分:游离/总前列腺特异性抗原分析比值、年龄特异性参考范围及前列腺特异性抗原密度的回顾性分析
Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4.
8
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.检测血清中前列腺特异性抗原作为前列腺癌的筛查试验。
N Engl J Med. 1991 Apr 25;324(17):1156-61. doi: 10.1056/NEJM199104253241702.
9
[Detection of cancer of the prostate. A study of 600 cases].
Ann Urol (Paris). 1990;24(1):37-41.
10
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).欧洲前列腺癌筛查随机研究(鹿特丹地区)活检结果的预测因素
Prostate. 1999 Jun 1;39(4):316-22. doi: 10.1002/(sici)1097-0045(19990601)39:4<316::aid-pros14>3.0.co;2-o.

引用本文的文献

1
The efficiency of the serum prostate specific antigen levels in diagnosing prostatic enlargements.血清前列腺特异性抗原水平在诊断前列腺增生中的效率。
J Clin Diagn Res. 2013 Jan;7(1):82-4. doi: 10.7860/JCDR/2012/4926.2676. Epub 2012 Nov 10.
2
Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal.在塞内加尔通过直肠指检和前列腺特异性抗原检测进行前列腺癌筛查。
ISRN Oncol. 2011;2011:943704. doi: 10.5402/2011/943704. Epub 2011 Jul 10.
3
Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.
基于对已发表研究的系统评价对前列腺癌筛查、诊断及分期的成本分析
Prev Chronic Dis. 2007 Oct;4(4):A100. Epub 2007 Sep 15.
4
Adjusting for treatment refusal in rationing decisions.在配给决策中考虑治疗拒绝因素。
BMJ. 2006 Mar 4;332(7540):542-4. doi: 10.1136/bmj.332.7540.542.
5
Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.使用血清前列腺特异性抗原筛查前列腺癌:芬兰一项基于人群的随机试点研究。
Br J Cancer. 1996 Aug;74(4):568-72. doi: 10.1038/bjc.1996.402.
6
Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer?
World J Urol. 1996;14(1):53-8. doi: 10.1007/BF01836345.
7
Cancer of the prostate.
BMJ. 1994 Mar 19;308(6931):780-4. doi: 10.1136/bmj.308.6931.780.
8
Radical prostatectomy and prostate cancer screening: the need for national audit and research.根治性前列腺切除术与前列腺癌筛查:全国性审计与研究的必要性
Ann R Coll Surg Engl. 1994 Nov;76(6):367-72.
9
Prostate cancer screening (United States).
Cancer Causes Control. 1995 May;6(3):267-74. doi: 10.1007/BF00051798.
10
Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group.前列腺疾病:基层医疗团队的管理方案。英国前列腺组织工作小组报告。
Postgrad Med J. 1995 Mar;71(833):136-42. doi: 10.1136/pgmj.71.833.136.